The Institute adopts a transdisciplinary and translational approach, bringing into contact, upstream, researchers and engineers from very different domains (mathematics, physics, chemistry, biology, IT, electronics, nanotechnology, etc.) and downstream physicians and manufacturers.
Each field has its own challenges:
The main challenges are to increase the sensitivity and definition of the images obtained, speed up data analysis, improve image reconstruction and reduce the doses of radiation emitted to patients for radiation examinations.
The challenges here include improving screening effectiveness, evaluating the toxicity and bioavailability of possible drugs early on, and simplifying and accelerating the time it takes for drugs to be developed.
One of the major objectives is to develop early diagnostic tests, in vitro and in vivo, which are specific to and reproducible for new diseases or diseases for which diagnosis is currently at too late a stage.
Surgery and interventional techniques
The main breakthroughs will particularly focus on the reliability, biocompatibility and performances of these technologies, miniaturization and automation of interventional tools, and software programs that create images of the operation sites.
Identifying risk factors associated with diseases, making diagnoses sooner, improving treatment efficacy with account taken of patient comfort … these are just some of the challenges involved in developing better disease prevention and treatment.
Beyond essential knowledge of physiology and human diseases, new technological approaches can also make a significant contribution to medical progress. Such progress results today from a close working partnership between researchers and engineers, biologists and physicians.
In full development, these health technologies can be split into four main areas.
Director : Franck Lethimonnier
Deputy Director : Yves Remond